ERX - A thread for everyone

Lucky:

I think there is a possibility that the money will be coming due to the fact that 2 American companies are trying out ERX' tech. I do see your point re Irish-AIM. If the books are not cooked the asset value seems to be about 5 million, this of course would need to be audited to be sure and most likely is mainly patents.

What people like Mike fail to see or would not admit is that they have been fooled into thinking milestone payments were taking place rather soon and that ERX would not need more money. This of course has proven wrong. The latest results even mention the interest of the company to develop new products as a hedge in case the existing ones do not deliver, this is further evidence that the company is not sure that the milestone payments will materialise. It is also indicative of further cash requirements. Here is where any institution or private investor that is willing to give them more money will have to make clear that a cost reduction program has to be instrumented.

If the directors want to hedge they should look at safer more immediate sources to make money out of the money they get. For instance a better hedge would be to buy shares in other biotecs with better fundamentals like oxb, antisoma, etc, or maybe even in gwp while observing the principle that commands "cash is king"

They need to reduce cost so that the money that is left and the incoming is used for protecting its IP portfolio if necessary and to maintain basic operations running while erx waits for the results from the US.

In conclusion this share is an absolute gamble and anybody deciding to buy, hold or sell should be aware that ERX is a very dangerous play thus if successful could yield great returns if not the abyss awaits. Hence an absolute gamble for long term risk lovers who are willing to gamble loosing all their investment (closer to lottery or horse races) and provided ERX manages to reduce cost but certainly not for orphans and widows.




All the best